Dr. Tsai currently serves as a Senior Surgical Pathologist for NeoGenomics. Prior to joining Neogenomics, Dr. Tsai was responsible for the medical directorship of numerous urologic groups as well as the Medical Director of Houston Plus Diagnostics Laboratory. Dr. Tsai received his MD and PhD from the University of California, Irvine, and spent five years at UCLA for his residency and fellowships in both Surgical Pathology and Cytopathology. Dr. Tsai is board-certified in Anatomic Pathology, Clinical Pathology, and Cytopathology.
Henry Tsai, MD PhD
Senior Surgical Pathologist